Diabetes mellitus (diabetes) is a highly prevalent chronic metabolic disorder that interferes with the body’s ability to produce or effectively use insulin.Insulin is a hormone that regulates blood sugar. Hyperglycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body’s systems, especially the nerves and blood vessels. Each year more and more people live with this condition, which can result in life-changing complications. According to WHO, in 2015, an estimated 1.6 million deaths were directly caused by diabetes. In addition, to the 415 million adults who are estimated to have diabetes globally in 2015, there are 318 million adults with impaired glucose tolerance, which puts them at high risk of developing the chronic disease in the future. “Meticulous Research” in its latest publication states that, the “global Diabetes Care Devices Market is expected to grow at a CAGR of 5.3% from 2017 to 2022 to reach $26,710.3 million by 2022.”
This growth is primarily driven by increasing incidence &prevalence of diabetes, technological advancements, rise in obesity rate, increasing adoption of sedentary lifestyle & improper diet, and increasing need for faster and safer diagnosis & treatment of diabetes.
Scope of the Report
Market by Type
- Diabetes monitoring devices
– Test strips
– Self-monitoring devices
– Continuous blood glucose monitoring devices
– Haemoglobin A1c testing kits
- Insulin delivery devices
– Insulin Pens
– Insulin Syringes
– Insulin Pumps
– Insulin Jet Injectors
Browse in-depth report on http://www.meticulousresearch.com/product/diabetes-care-devices-market-2022/
Diabetes mellitus is one the most dreaded life style disease condition which is spreading as an epidemic across the globe. Large number of individuals who meet the current criteria for diabetes mellitus remain asymptomatic and unaware of having this disorder.The incidence & prevalence of diabetes has significantly increased in the last decade and is also expected to rise in the coming future. According to the International Diabetes Federation (IDF), globally, 415 million people had diabetes in 2015; this number is expected to increase to 642 million by 2040. In the North America, the diabetes population was around 44.3 million in 2015. Similarly, according to the IDF, the number of people with diabetes in Europe was 59.8 million in 2015, which is expected to rise to 71.1 million by 2040. Significant growth is observed in diabetes prevalence in BRIC countries as well. As of 2015, there were around 109.6 million people living with diabetes in China and is expected to grow to 150.7 million by 2035. It has the world’s largest diabetes population, followed by India with 69.2 million in 2015 (projected – 123.5.0 million by 2035).
The significant growth in diabetes population is primarily attributed to the rising obesity rates across the globe, and increasing sedentary lifestyle with poor diets and lowered physical inactivity. According to the World Health Organization (WHO), in 2014, around 39% adults were overweight. Of these about 13% of the world’s adult population were obese; and almost half the world will be overweight or obese by 2030. With increasing levels of obesity and physical inactivity among children in many countries, type 2 diabetes in childhood has the potential to become a global public health issue, leading to serious health outcomes. The ignorance of the diabetes at early stage can lead to many severe complications, including increased risk of cardiovascular diseases and kidney disorders and thereby huge financial implications.
Thus, the rising diabetic population across the globe will propel the number of people who must be monitored with the periodic monitoring of their blood glucose, thereby leading to a growing demand for diabetes care devices.
The report provides meticulous analysis of diabetes care devices market on the basis of monitoring devices (test strips, self-monitoring devices, CGM devices, lancets, hemoglobin A1c testing kits) and insulin delivery devices (insulin pens, insulin syringes, insulin pumps, insulin jet injectors), and geography.
The key players analyzed in the Diabetes Care Devices Market are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche AG. (Switzerland), Johnson & Johnson (U.S.), Medtronic Plc. (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France).
Key Topics Covered in This Report:
- Research Methodology
- Executive Summary
- Market Share Analysis
- Market Insights
- Global Diabetes Care Device Market, By Monitoring Devices
- Global Diabetes Care Device Market, By Insulin Delivery Devices
- Geographic Analysis
- Competitive Landscape
- Company Profiles
Diabetes Care Devices Market by Monitoring Devices (Test Strips, Self-Monitoring Devices, CGM Devices, Lancets, Hemoglobin A1c Testing Kits) and Insulin Delivery Devices (Insulin Pens, Insulin Syringes, Insulin Pumps, Insulin Jet Injectors) – Global Opportunity Analysis and Industry Forecast To 2022.
Get Free sample report here: https://www.meticulousresearch.com/download-sample-report/?cp_id=3438